SR-1664

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSR-1664
Drug Alias NamePPAR gamma modulator (University of Texas Medical Branch/The Scripps Research Institute)SR-1664
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ modulators
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetes MellitusAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A